Last reviewed · How we verify

Maintenance of Healing Gastroesophageal Reflux — Treatment Landscape & Competitive Intelligence

Maintenance of Healing Gastroesophageal Reflux (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Maintenance of Healing Gastroesophageal Reflux, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Aciphex rabeprazole Waylis Proton Pump Inhibitor Potassium-transporting ATPase 1999-01-01
Aciphex Aciphex University of Utah Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3
Rabeprazol Rabeprazol Janssen-Cilag, S.A. Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Janssen-Cilag, S.A. · 1 drug in Maintenance of Healing Gastroesophageal Reflux
  2. University of Utah · 1 drug in Maintenance of Healing Gastroesophageal Reflux
  3. Waylis · 1 drug in Maintenance of Healing Gastroesophageal Reflux

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Maintenance of Healing Gastroesophageal Reflux:

Cite this brief

Drug Landscape (2026). Maintenance of Healing Gastroesophageal Reflux — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/maintenance-of-healing-gastroesophageal-reflux. Accessed 2026-06-11.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing